4th Quarter - Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$750,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Labor Issues/Antitrust/Workplace LBR

Employee Free Choice Act - monitoring status of bill HR 1409 and S 560

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS LD, Rep. Artur Davis
CANDIE PHIPPS —
PAUL ROMNESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1409 (111th)

Copyright/Patent/Trademark CPT

Patent reform, Patent settlements; H.R. 1706 and S. 5369

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS LD, Rep. Artur Davis
CANDIE PHIPPS —
PAUL ROMNESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 5369 (111th), H.R. 1706 (111th)

Tariff (miscellaneous tariff bills) TAR

Miscellaneous Tariff Bill; relating to the duty suspension of cyclopropylaminonicotine acid

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS LD, Rep. Artur Davis
CANDIE PHIPPS —
PAUL ROMNESS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Health care reform: America's Affordable Health Choices Act, HR 3200 (Education and Labor, Ways and Means, House Energy and Commerce committee drafts), Affordable Health Choices Act, and America's Healthy Future Act (S 1679: Senate HELP and S 1796: Senate Finance committee drafts); pricing/rebates, importation, coverage, comparative effectiveness, biosimilars, transparency

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS LD, Rep. Artur Davis
CANDIE PHIPPS —
PAUL ROMNESS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3200 (111th)

Medicare/Medicaid MMM

Medicare Part D preservation in health reform Rebates, Medicare, Medicaid and Medicaid expansion in health reform

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS LD, Rep. Artur Davis
CANDIE PHIPPS —
PAUL ROMNESS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Clean Air and Water (quality) CAW

Pharmaceuticals in the environment - drug take back programs; HR 1191

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS LD, Rep. Artur Davis

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1191 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.